Skip to main content
Log in

Trends in lung cancer diagnosis and care among visible minorities and non-visible minorities in Canada

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Background

Identifying factors that influence the diagnosis and treatment of lung cancer is an important public health initiative. Various sociodemographic factors, including race and ethnicity, may influence an individual’s risk of developing lung cancer, as well as access to relevant diagnostic and therapeutic procedures.

Methods

Data from the 2006 Canadian long-form census were cross-linked with the Canadian Cancer Registry and hospital data to determine rates of lung cancer diagnosis among visible minorities and non-visible minorities in Canada, and to assess for differences in rates of hospital-based procedures pertaining to a lung cancer diagnosis based on visible-minority status. Individuals were allocated into six visible-minority categories, and separate results were generated nationally and across seven regions. Multivariate logistic regression controlled for relevant confounders.

Results

Rates of lung cancer were significantly lower among visible minorities versus non-visible minorities (329 versus 1108 cases per 100 000). This result is consistent across all visible-minority subgroups. Among those with a diagnosis of lung cancer, procedure rates were higher for all visible minorities nationally (53.4% [95% CI 53.2–53.6]). Multivariable analysis demonstrated higher procedure rates in general for visible minorities with a lung cancer diagnosis compared to non-visible minorities (OR 1.158 95% CI 1.053–1.273).

Interpretation

In Canada, visible minorities experience lower rates of lung cancer diagnosis than non-visible minorities. Among those with a lung cancer diagnosis, we did not identify any negative disparities in rates of relevant diagnostic or therapeutic procedures, based on visible-minority status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data used for this project were accessed through the Statistics Canada Research Data centre program. Data are only available at highly secure facilities to researchers who are deemed Statistics Canada employees after a thorough background check. As a result, data are not publicly available. For more information see https://www.statcan.gc.ca/en/microdata/data-centres.

References

  1. Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada. Canadian Cancer Statistics 2021. Toronto, ON: Canadian Cancer Society; 2021. Available at: cancer.ca/Canadian-Cancer-Statistics-2021-EN (accessed April 2022).

  2. Canadian Task Force on Preventive Health Care [Internet]. Lung Cancer (2016) – Summary of recommendations for clinicians and policy-makers. Available at: https://canadiantaskforce.ca/guidelines/published-guidelines/lung-cancer/ (accessed October 2021).

  3. Mitra D, Shaw A, Tjepkema M, Peters P (2015) Social determinants of lung cancer incidence in Canada: a 13-year prospective study. Health Rep 26(6):12–20

    PubMed  Google Scholar 

  4. Canadian Partnership Agains Cancer. Lung Cancer and Equity (2020). Available at: https://www.partnershipagainstcancer.ca/topics/lung-cancer-equity/ (accessed April 2022)

  5. Benchimol EI, Smeeth L, Guttmann A et al (2015) RECORD working committee. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 12(10):e1001885

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dawe DE, Singh H, Wickramasinghe L et al (2017) Geographical variation and factors associated with non-small cell lung cancer in manitoba. Can Respir J 2017:7915905. https://doi.org/10.1155/2017/7915905

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ezer N, Mhango G, Bagiella E et al (2020) Racial disparities in resection of early Stage non-small cell lung cancer: variability among surgeons. Med Care 58(4):392–398. https://doi.org/10.1097/MLR.0000000000001280

    Article  PubMed  Google Scholar 

  8. Wolf A, Alpert N, Tran B et al (2019) Persistence of racial disparities in early-stage lung cancer treatment. J Thorac Cardiovasc Surg 157(4):1670-1679.e4. https://doi.org/10.1016/j.jtcvs.2018.11.108

    Article  PubMed  Google Scholar 

  9. American Cancer Society. Cancer Facts & Figures 2020. Atlanta: American Cancer Society; 2020

  10. Hardy D, Liu CC, Xia R et al (2009) Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer 115(10):2199–2211. https://doi.org/10.1002/cncr.24248

    Article  PubMed  Google Scholar 

  11. Lin JJ, Mhango G, Wall MM et al (2014) Cultural factors associated with racial disparities in lung cancer care. Ann Am Thorac Soc 11(4):489–495. https://doi.org/10.1513/AnnalsATS.201402-055OC

    Article  PubMed  PubMed Central  Google Scholar 

  12. Haddad DN, Sandler KL, Henderson LM et al (2020) Disparities in lung cancer screening: a review. Ann Am Thorac Soc 17(4):399–405. https://doi.org/10.1513/AnnalsATS.201907-556CME

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rvera MP, Katki HA, Tanner NT et al (2020) Addressing disparities in lung cancer screening eligibility and healthcare access .an official american thoracic society statement. Am J Respir Crit Care Med. 202(7):e95–e112. https://doi.org/10.1164/rccm.202008-3053ST

    Article  Google Scholar 

  14. National Lung Screening Trial Research Team et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 365(5):395–409.

  15. Ha SY, Choi SJ, Cho JH et al (2015) Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR. Oncotarget 6(7):5465–5474. https://doi.org/10.18632/oncotarget.2925

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. McFadgen.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix A

Appendix A

Canadian classification of health intervention code (CCI)

Description

Therapeutic intervention codes

 

1.GR.87.^^

Excision partial, lobe of lung

 Lingulectomy, Lobectomy partial, Segmentectomy, lobe of lung [with removal of two segments (e.g., partial excision of two different lobes)], Wedge resection

1.GR.89.^^

Excision total, lobe of lung

 Lobectomy complete, lobe of lung (with or without stapler)

1.GR.91.^^^

Excision radical, lobe of lung

 Dissection of brachial plexus, bronchus, ribs (transverse process), intercostal structures and sympathetic nerves along with the lungs

 Lobectomy (sleeve), lobe of lung with excision of a portion of the bronchus and subsequent reanastomosis [with chest wall resection; removal of adjoining/attached lymph nodes]

Diagnostic intervention codes

 

2.GM.70.^^

Inspection, bronchus

 Bronchoscopy [without biopsy]

2.GM.71.^^

Biopsy, bronchus

 Bronchoscopy with bronchial tissue biopsy

 Bronchoscopy with brush biopsy; using open approach

2.GT.70.^^

Inspection, lung

 using open approach

2.GT.71.^^

Biopsy, lung

 Bronchoscopy with lung tissue biopsy using endoscopic approach and needle aspiration

 Bronchoscopy with trans bronchial lung biopsy using VATS; percutaneous (needle) approach; or open approach

2.GV.70.^^

Inspection, pleura

 Pleuroscopy (using open approach or VATS)

2.GV.71.^^

Biopsy, pleura

 Using VATS, percutaneous approach or open approach

2.GW.70.^^

Inspection, mediastinum

 Mediastinoscopy, or using open approach (anterior mediastinotomy)

2.GW.71.^^

Biopsy, mediastinum

 Mediastinoscopy, percutaneous (needle) approach, or open approach (anterior mediastinotomy)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McFadgen, H., Lethbridge, L., Dunbar, M. et al. Trends in lung cancer diagnosis and care among visible minorities and non-visible minorities in Canada. Cancer Causes Control 35, 575–582 (2024). https://doi.org/10.1007/s10552-023-01816-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-023-01816-6

Keywords

Navigation